226 related articles for article (PubMed ID: 38364259)
1. Yangyinghuoxue decoction exerts a treatment effect on hepatic fibrosis by PI3K/AKT pathway in rat model: based on the network pharmacology and molecular docking.
Bai YM; Liang S; Zhou B
Aging (Albany NY); 2024 Feb; 16(4):3773-3789. PubMed ID: 38364259
[TBL] [Abstract][Full Text] [Related]
2. Integration of network pharmacology and serum medicinal chemistry to investigate the pharmacological mechanisms of QiZhuYangGan Decoction in the treatment of hepatic fibrosis.
Deng JW; Yuan S; Shi LP; Chen X; Liu J; Chen ZW; Tan KY; Yang Q; Cao WF
J Ethnopharmacol; 2024 Apr; 323():117730. PubMed ID: 38190954
[TBL] [Abstract][Full Text] [Related]
3. Integrated strategy of network pharmacology, molecular docking, HPLC-DAD and mice model for exploring active ingredients and pharmacological mechanisms of Penthorum chinense Pursh against alcoholic liver injury.
Jiang Y; Zhong M; Zhan H; Tao X; Zhang Y; Mao J; Geng Z; Gao B
J Ethnopharmacol; 2022 Nov; 298():115589. PubMed ID: 35926779
[TBL] [Abstract][Full Text] [Related]
4. [Mechanism of Wuling Capsules against hepatic fibrosis based on network pharmacology and animal experiments].
Li N; Ren SJ; Zhou R; Song ZX; Liu YR; Tang ZS; Zhou JP; Cao ZJ
Zhongguo Zhong Yao Za Zhi; 2023 Oct; 48(19):5365-5376. PubMed ID: 38114126
[TBL] [Abstract][Full Text] [Related]
5. Hovenianin A Alleviates Hepatic Fibrosis by Inhibiting the PI3K/AKT Pathway in TGF-β1-Induced HSCs Based on Network Pharmacology and Transcriptomic Analysis.
Kuang X; Ma T; Cai W; Yang J; Sun B; Zhang X; Liu B; Wang S; Xu F
Chem Biodivers; 2023 Mar; 20(3):e202201110. PubMed ID: 36825591
[TBL] [Abstract][Full Text] [Related]
6. Mechanisms of Xiaochaihu Decoction on Treating Hepatic Fibrosis Explored by Network Pharmacology.
Qiang R; Zhang Y; Wang Y
Dis Markers; 2022; 2022():8925637. PubMed ID: 36246566
[TBL] [Abstract][Full Text] [Related]
7. Understanding apoptotic induction by Sargentodoxa cuneata-Patrinia villosa herb pair via PI3K/AKT/mTOR signalling in colorectal cancer cells using network pharmacology and cellular studies.
Mu BX; Li Y; Ye N; Liu S; Zou X; Qian J; Wu C; Zhuang Y; Chen M; Zhou JY
J Ethnopharmacol; 2024 Jan; 319(Pt 3):117342. PubMed ID: 37879505
[TBL] [Abstract][Full Text] [Related]
8. A network pharmacology approach and experimental validation to investigate the anticancer mechanism and potential active targets of ethanol extract of Wei-Tong-Xin against colorectal cancer through induction of apoptosis via PI3K/AKT signaling pathway.
Lin F; Zhang G; Yang X; Wang M; Wang R; Wan M; Wang J; Wu B; Yan T; Jia Y
J Ethnopharmacol; 2023 Mar; 303():115933. PubMed ID: 36403742
[TBL] [Abstract][Full Text] [Related]
9. Mechanism of Bazhen decoction in the treatment of colorectal cancer based on network pharmacology, molecular docking, and experimental validation.
Lu S; Sun X; Zhou Z; Tang H; Xiao R; Lv Q; Wang B; Qu J; Yu J; Sun F; Deng Z; Tian Y; Li C; Yang Z; Yang P; Rao B
Front Immunol; 2023; 14():1235575. PubMed ID: 37799727
[TBL] [Abstract][Full Text] [Related]
10. Network pharmacology, molecular docking and experimental verification of the mechanism of huangqi-jixuecao herb pair in treatment of peritoneal fibrosis.
Dai H; Shan Y; Yu M; Wang F; Zhou Z; Sun J; Sheng L; Huang L; Sheng M
J Ethnopharmacol; 2024 Jan; 318(Pt A):116874. PubMed ID: 37437794
[TBL] [Abstract][Full Text] [Related]
11. Erianin, the main active ingredient of Dendrobium chrysotoxum Lindl, inhibits precancerous lesions of gastric cancer (PLGC) through suppression of the HRAS-PI3K-AKT signaling pathway as revealed by network pharmacology and in vitro experimental verification.
Wang Y; Chu F; Lin J; Li Y; Johnson N; Zhang J; Gai C; Su Z; Cheng H; Wang L; Ding X
J Ethnopharmacol; 2021 Oct; 279():114399. PubMed ID: 34246740
[TBL] [Abstract][Full Text] [Related]
12. Network Pharmacology and Molecular Docking Reveal the Mechanism of
Deng J; Qin L; Zhou Z
Drug Des Devel Ther; 2023; 17():2335-2351. PubMed ID: 37576085
[TBL] [Abstract][Full Text] [Related]
13. Network pharmacology-based prediction and validation of the active ingredients and potential mechanisms of the Huangxiong formula for treating ischemic stroke.
Zhao S; Zhang P; Yan Y; Xu W; Li J; Wang L; Wang N; Huang Y
J Ethnopharmacol; 2023 Aug; 312():116507. PubMed ID: 37080367
[TBL] [Abstract][Full Text] [Related]
14. Investigation of the potential mechanism of the Shugan Xiaozhi decoction for the treatment of nonalcoholic fatty liver disease based on network pharmacology, molecular docking and molecular dynamics simulation.
Yang R; Yang H; Jiang D; Xu L; Feng L; Xing Y
PeerJ; 2022; 10():e14171. PubMed ID: 36389420
[TBL] [Abstract][Full Text] [Related]
15. The mechanism of peach kernel and safflower herb-pair for the treatment of liver fibrosis based on network pharmacology and molecular docking technology: A review.
Huang L; Yu Q; Peng H; Zhen Z
Medicine (Baltimore); 2023 Apr; 102(16):e33593. PubMed ID: 37083803
[TBL] [Abstract][Full Text] [Related]
16. Network pharmacology and experimental verification of the potential mechanism of Er-Xian decoction in aplastic anemia.
Ye M; Liu G; Yang Y; Yang H; Ren J; Chen W; Gao Z
Sci Rep; 2023 Oct; 13(1):17385. PubMed ID: 37833363
[TBL] [Abstract][Full Text] [Related]
17. Mechanism of Key Ingredient of Astragalus membranaceus on Lung Adenocarcinoma via PI3K/AKT Signaling Clarified by Utilizing Network Pharmacology Approach and Experimental Validation.
Wang YC; Hui JR; Xiao G; Ma QL
Chin J Integr Med; 2023 Mar; 29(3):244-252. PubMed ID: 36044117
[TBL] [Abstract][Full Text] [Related]
18. Fufang Shenhua tablet inhibits renal fibrosis by inhibiting PI3K/AKT.
Li R; Shi C; Wei C; Wang C; Du H; Liu R; Wang X; Hong Q; Chen X
Phytomedicine; 2023 Jul; 116():154873. PubMed ID: 37257328
[TBL] [Abstract][Full Text] [Related]
19. A network pharmacology approach to investigating the mechanism of Tanshinone IIA for the treatment of liver fibrosis.
Shi MJ; Yan XL; Dong BS; Yang WN; Su SB; Zhang H
J Ethnopharmacol; 2020 May; 253():112689. PubMed ID: 32101775
[TBL] [Abstract][Full Text] [Related]
20. Network pharmacology analysis combined with experimental validation to explore the therapeutic mechanism of Schisandra Chinensis Mixture on diabetic nephropathy.
Ma Y; Deng Y; Li N; Dong A; Li H; Chen S; Zhang S; Zhang M
J Ethnopharmacol; 2023 Feb; 302(Pt A):115768. PubMed ID: 36280016
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
